German company HASOMED, headquartered in Magdeburg, specializes in software and hardware solutions for neurological diagnostics and rehabilitation.
In addition to being a market leader in Europe in the field of computer-aided cognitive therapy for stroke and Traumatic Brain Injury (TBI) patients with the RehaCom program, HASOMED offers Functional Electrical Stimulation for Spinal Cord Injury (SCI) and stroke patients, devices for hand therapy, a mobile gait analysis system and a unique swallowing measurement and therapy system for dysphagia patients.
With partners in 37 countries worldwide except Asia, the company applied for the EU Gateway | Business Avenues programme in hopes of expanding its business in the region.
In December 2017, HASOMED participated in the EU-funded mission to China together with other promising Healthcare & Medical Technologies companies from Europe. China was unequivocally a country with potential for the German company, due to its rapidly developing medical technology market.
Early on, HASOMED realized how to make maximum use of the synergies generated by participating in a programme with the scale of EU Gateway | Business Avenues.
We have received excellent support and guidance from the EU Gateway | Business Avenues programme, starting with the provision of country-specific market knowledge by specialists in the programme, through targeted matchmaking in preparation for trade fairs in the pavilions under the EU flag. - Ferry Tomaszyk, International Sales Manager, HASOMED (Germany)
Under the patronage of the EU, HASOMED benefitted from increased visibility and credibility with its Asian counterparts. Thanks to a rigorous matchmaking process, the company’s representatives were able to meet highly targeted local companies that were interested in HASOMED’s solutions.
In under one year since the mission, the company is reaping early successes, thanks to the close cooperation with the EU Gateway | Business Avenues team. Two newly established business relationships in China have been particularly successful.
Contrary to the company’s initial approach of only looking for promising sales partners in China, business plans have evolved further, thanks to the programme.
In addition to taking over the distribution of its products in China, thanks to these new partners, the company is already working closely with important scientific partners at renowned institutions.
For HASOMED, this means significantly better access to key opinion leaders, an even more precise adaptation of its products to the needs of the Chinese medical market and a wide range of options for imparting product knowledge.
In addition, HASOMED has launched a promising joint venture for the first time in the history of the company, by starting to have one of its products manufactured in China.
Moreover, the company is already in the process of developing a completely new product together with its Chinese partners. This close cooperation is to have a very positive effect on mutual trust and ultimately on business success in China.
Since the first mission participation, the company looked to further expand its reach in Asia. With EU Gateway | Business Avenues support, it discovered new markets and started a potential expansion to Korea, Thailand, Singapore and the Philippines.
In all the before-mentioned Asian countries, HASOMED was able to acquire new business partners and generate sales. Expressly, this means an increase from 37 to 43 sales partners overall.
The company’s representatives credit this success to the good cooperation with the EU Gateway | Business Avenues team and the strategic, organizational, logistical and financial support of the programme.
Your company could benefit from the programme too.
Check out upcoming EU Gateway | Business Avenues openings and apply!